Ensuring Access to Essential Drugs Act

Hozzl · 2025-03-21T18:28:55Z

Explore the details of House Bill 1922 Ensuring Access to Essential Drugs Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/21/2025, 6:28 PM

Summary of Bill HR 1922

Bill 119 HR 1922, also known as the "Medicare Part D Manufacturer Discount Exemption Act," aims to make changes to the Medicare program under Title XVIII of the Social Security Act. Specifically, this bill seeks to exempt certain drugs from the Part D manufacturer discount program.

The Part D manufacturer discount program was established to provide discounts on prescription drugs to Medicare beneficiaries. However, some drugs are currently required to participate in this program, which can limit access to certain medications for patients.

If passed, Bill 119 HR 1922 would allow certain drugs to be exempt from the Part D manufacturer discount program. This exemption would provide more flexibility for manufacturers and potentially increase access to a wider range of medications for Medicare beneficiaries. Overall, this bill addresses concerns about access to prescription drugs for Medicare beneficiaries and aims to improve the efficiency and effectiveness of the Medicare program. It will be important to monitor the progress of this bill as it moves through the legislative process to see how it may impact Medicare beneficiaries and the healthcare system as a whole.

Congressional Summary of HR 1922

Ensuring Access to Essential Drugs Act

This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.

Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1922

Bill HR 1922 is currently in the status of Bill Introduced since March 6, 2025. Bill HR 1922 was introduced during Congress 119 and was introduced to the House on March 6, 2025. Bill HR 1922's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of March 6, 2025